Novo Nordisk keeps Buy rating from Citi on Ozempic trials
03/06/2024 04:18
Citi analysts maintained a Buy rating on Novo Nordisk (NVO) stock over the results of an Ozempic trial showing that the GLP-1 weight loss drug delayed the progression of chronic kidney disease in patients, cutting the risk of a cardiac event by 24%. Yahoo Finance Anchors Josh Lipton and Julie Hyman break down the latest development for Novo Nordisk and its rating from Citi, and how it may affect the company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino

Barrons.com
Coinbase Stock Is Riding Bitcoin’s Wave. A Major Court Decision Looms.
Coinbase Global stock is skyrocketing on the back of Bitcoin seeming inexorable rise. Nine months after the Securities and Exchange Commission filed a case against Coinbase for allegedly operating an unregistered securities exchange, the judge in the case will likely soon rule on whether the agency has purview over much of the crypto market in the first place. If U.S. District Judge Katherine Polk Failla says the SEC doesn’t have purview, Coinbase and other crypto projects would likely see an immediate boost.

The Wall Street Journal
Five Signs That Market Breadth Is Picking Up
Shares of the Magnificent Seven are making room for other stocks on their way up, which some investors say is a sign of a [healthier stock market less-dependent](https://www.wsj.com/finance/rise-in-stocks-bonds-crypto-gold-683f0e91) on the performance of a few big companies.

CoinDesk
Bitcoin Hit a Record High. Here's What Might Happen Next
Bitcoin hit a record $69,325, its highest level since November 2021 on a flurry of volatility buoyed by demand from spot BTC exchange-traded funds (ETFs). Unlike previous cycles, it almost instantly fell back as bearish traders wrangled for control.



Benzinga
Mark Cuban Attacks Trump, Endorses Biden in Fiery Statement
Mark Cuban’s acknowledgment of Tesla Inc. (NASDAQ:TSLA) interest in his Cost Plus Drugs initiative, which focuses on reducing healthcare costs, has significant implications for investors, particularly those watching Real Estate Investment Trusts (REITs) like Welltower Inc. (NYSE:WELL) and Digital Realty Trust (NYSE:DLR). This development is part of a larger conversation that’s been brewing, fueled by the ongoing, very public dialogue between Cuban and Elon Musk. Their exchanges have been marked